{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T23:55:05Z","timestamp":1790380505947,"version":"4.1.0"},"reference-count":38,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2019.10012","type":"journal-article","created":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T08:15:26Z","timestamp":1549268126000},"source":"Crossref","is-referenced-by-count":12,"title":["Prognostic value of KRAS\/TP53\/PIK3CA in non\u2011small cell lung cancer"],"prefix":"10.3892","author":[{"given":"Jiayi","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Changhai Hospital, Second Military Medical University, Shanghai 200433, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiping","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Changhai Hospital, Second Military Medical University, Shanghai 200433, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Psychology, Second Military Medical University, Shanghai 200433, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Chai","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Changhai Hospital, Second Military Medical University, Shanghai 200433, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Bai","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Changhai Hospital, Second Military Medical University, Shanghai 200433, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2019,2,4]]},"reference":[{"key":"key20200714085652_b1-ol-0-0-10012","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3322\/caac.21208","article-title":"Cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"key20200714085652_b2-ol-0-0-10012","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1002\/ijc.29227","article-title":"Cancer survival in China, 2003\u20132005: A population-based study","volume":"136","author":"Zeng","year":"2015","journal-title":"Int J Cancer"},{"key":"key20200714085652_b3-ol-0-0-10012","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.cllc.2012.01.004","article-title":"Personalized medicine for non-small-cell lung cancer: Implications of recent advances in tissue acquisition for molecular and histologic testing","volume":"13","author":"Moreira","year":"2012","journal-title":"Clin Lung Cancer"},{"key":"key20200714085652_b4-ol-0-0-10012","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1097\/JTO.0b013e318283d958","article-title":"KRAS mutations as prognostic and predictive markers in non-small cell lung cancer","volume":"8","author":"Martin","year":"2013","journal-title":"J Thorac Oncol"},{"key":"key20200714085652_b5-ol-0-0-10012","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1097\/JTO.0b013e31825493eb","article-title":"Development of PI3K\/AKT\/mTOR pathway inhibitors and their application in personalized therapy for non-small-cell lung cancer","volume":"7","author":"Papadimitrakopoulou","year":"2012","journal-title":"J Thorac Oncol"},{"key":"key20200714085652_b6-ol-0-0-10012","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1200\/JCO.2016.71.2893","article-title":"Pooled analysis of the prognostic and predictive effects of TP53 comutation status combined with KRAS or EGFR mutation in early-stage resected non-small-cell lung cancer in four trials of adjuvant chemotherapy","volume":"35","author":"Shepherd","year":"2017","journal-title":"J Clin Oncol"},{"key":"key20200714085652_b7-ol-0-0-10012","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.chest.2016.10.010","article-title":"The eighth edition lung cancer stage classification","volume":"151","author":"Detterbeck","year":"2017","journal-title":"Chest"},{"key":"key20200714085652_b8-ol-0-0-10012","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1373\/clinchem.2014.229328","article-title":"Noninvasive prenatal testing for Wilson disease by use of circulating single-molecule amplification and resequencing technology (cSMART)","volume":"61","author":"Lv","year":"2015","journal-title":"Clin Chem"},{"key":"key20200714085652_b9-ol-0-0-10012","first-page":"2495","article-title":"New response evaluation criteria in solid tumours-revised RECIST guideline (version 1.1)","volume":"36","author":"Watanabe","year":"2009","journal-title":"Gan To Kagaku Ryoho"},{"key":"key20200714085652_b10-ol-0-0-10012","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1016\/j.rmed.2010.08.005","article-title":"Staging of non-small cell lung cancer (NSCLC): A review","volume":"104","author":"Tsim","year":"2010","journal-title":"Respir Med"},{"key":"key20200714085652_b11-ol-0-0-10012","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1097\/PAT.0b013e328342629d","article-title":"What's new in non-small cell lung cancer for pathologists: The importance of accurate subtyping, EGFR mutations and ALK rearrangements","volume":"43","author":"Cooper","year":"2011","journal-title":"Pathology"},{"key":"key20200714085652_b12-ol-0-0-10012","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.lungcan.2009.11.020","article-title":"KRAS mutations and resistance to EGFR-TKIs treatment in patients with non-small cell lung cancer: A meta-analysis of 22 studies","volume":"69","author":"Mao","year":"2010","journal-title":"Lung Cancer"},{"key":"key20200714085652_b13-ol-0-0-10012","first-page":"2025","article-title":"Analysis of KRAS mutation in patients with non- small cell lung cancer","volume":"35","author":"Luo","year":"2014","journal-title":"Guangdong Med J"},{"key":"key20200714085652_b14-ol-0-0-10012","first-page":"9111","article-title":"Analysis of KRAS gene mutations in non-small cell lung cancer","volume":"7","author":"Yi","year":"2013","journal-title":"Zhonghua Lin Chuan Yi Shi Za Zhi (Electronic Edition)"},{"key":"key20200714085652_b15-ol-0-0-10012","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.18632\/oncotarget.2834","article-title":"PIK3CA mutations in non-small cell lung cancer (NSCLC): Genetic heterogeneity, prognostic impact and incidence of prior malignancies","volume":"6","author":"Scheffler","year":"2015","journal-title":"Oncotarget"},{"key":"key20200714085652_b16-ol-0-0-10012","first-page":"186","article-title":"Co-mutation of PIK3CA and other oncogenes in patients with non-small cell lung cancer","volume":"6","author":"Liang","year":"2015","journal-title":"Med J PUMCH"},{"key":"key20200714085652_b17-ol-0-0-10012","first-page":"553","article-title":"Mutations of p53 and K-ras genes as prognostic factors for non-small cell lung cancer","volume":"12","author":"Huang","year":"1998","journal-title":"Int J Oncol"},{"key":"key20200714085652_b18-ol-0-0-10012","doi-asserted-by":"publisher","first-page":"8424","DOI":"10.1073\/pnas.1431692100","article-title":"Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis","volume":"100","author":"Kato","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20200714085652_b19-ol-0-0-10012","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1001\/jama.2014.3741","article-title":"Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs","volume":"311","author":"Kris","year":"2014","journal-title":"Jama"},{"key":"key20200714085652_b20-ol-0-0-10012","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nature13385","article-title":"Cancer Genome Atlas Research Network: Comprehensive molecular profiling of lung adenocarcinoma","volume":"511","year":"2014","journal-title":"Nature"},{"key":"key20200714085652_b21-ol-0-0-10012","first-page":"652","article-title":"Relationship between EGFR and KRAS mutations and prognosis in Chinese patients with non-small cell lung cancer: A mutation analysis with real-time polymerase chain reaction using scorpion amplification refractory mutation system","volume":"41","author":"Gao","year":"2012","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"key20200714085652_b22-ol-0-0-10012","doi-asserted-by":"publisher","first-page":"865","DOI":"10.3349\/ymj.2013.54.4.865","article-title":"The impact of cigarette smoking on the frequency of and qualitative differences in KRAS mutations in Korean patients with lung adenocarcinoma","volume":"54","author":"Kim","year":"2013","journal-title":"Yonsei Med J"},{"key":"key20200714085652_b23-ol-0-0-10012","doi-asserted-by":"publisher","first-page":"e52093","DOI":"10.1371\/journal.pone.0052093","article-title":"Clinical significance of EML4-ALK fusion gene and association with EGFR and KRAS gene mutations in 208 Chinese patients with non-small cell lung cancer","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"key20200714085652_b24-ol-0-0-10012","first-page":"257","article-title":"Clinical Analysis of 107 NSCLC Patients Harboring KRAS Mutation","volume":"19","author":"Zhang","year":"2016","journal-title":"Zhongguo Fei Ai Za Zhi"},{"key":"key20200714085652_b25-ol-0-0-10012","doi-asserted-by":"crossref","first-page":"25046","DOI":"10.18632\/oncotarget.15337","article-title":"Concurrent gene alterations with EGFR mutation and treatment efficacy of EGFR-TKIs in Chinese patients with non-small cell lung cancer","volume":"8","author":"Hu","year":"2017","journal-title":"Oncotarget"},{"key":"key20200714085652_b26-ol-0-0-10012","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3389\/fonc.2014.00204","article-title":"Biomarkers that currently affect clinical practice in lung cancer: EGFR, ALK, MET, ROS-1, and KRAS","volume":"4","author":"Korpanty","year":"2014","journal-title":"Front Oncol"},{"key":"key20200714085652_b27-ol-0-0-10012","doi-asserted-by":"publisher","first-page":"1010428317694327","DOI":"10.1177\/1010428317694327","article-title":"Deep sequencing of the TP53 gene reveals a potential risk allele for non-small cell lung cancer and supports the negative prognostic value of TP53 variants","volume":"39","author":"Deben","year":"2017","journal-title":"Tumour Biol"},{"key":"key20200714085652_b28-ol-0-0-10012","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.lungcan.2017.01.011","article-title":"Mutations in TP53, PIK3CA, PTEN and other genes in EGFR mutated lung cancers: Correlation with clinical outcomes","volume":"106","author":"Vanderlaan","year":"2017","journal-title":"Lung Cancer"},{"key":"key20200714085652_b29-ol-0-0-10012","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/sj.bjc.6602258","article-title":"The role of RAS oncogene in survival of patients with lung cancer: A systematic review of the literature with meta-analysis","volume":"92","author":"Mascaux","year":"2005","journal-title":"Br J Cancer"},{"key":"key20200714085652_b30-ol-0-0-10012","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4419-9755-5_8","article-title":"Markers in lung cancer","author":"Lin","year":"2013"},{"key":"key20200714085652_b31-ol-0-0-10012","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1183\/09031936.00097311","article-title":"European Early Lung Cancer Consortium: Prognostic value of TP53, KRAS and EGFR mutations in nonsmall cell lung cancer: The EUELC cohort","volume":"40","author":"Scoccianti","year":"2012","journal-title":"Eur Respir J"},{"key":"key20200714085652_b32-ol-0-0-10012","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.molonc.2013.12.015","article-title":"Significance of TP53 mutations as predictive markers of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer","volume":"8","author":"Ma","year":"2014","journal-title":"Mol Oncol"},{"key":"key20200714085652_b33-ol-0-0-10012","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/mc.22077","article-title":"The influence of TP53 mutations on the prognosis of patients with early stage non-small cell lung cancer may depend on the intratumor heterogeneity of the mutations","volume":"54","author":"Lee","year":"2015","journal-title":"Mol Carcinog"},{"key":"key20200714085652_b34-ol-0-0-10012","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.lungcan.2016.11.018","article-title":"PIK3CA mutations as prognostic factor in squamous cell lung carcinoma","volume":"103","author":"Mcgowan","year":"2017","journal-title":"Lung Cancer"},{"key":"key20200714085652_b35-ol-0-0-10012","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1073\/pnas.0408864102","article-title":"Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic","volume":"102","author":"Kang","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20200714085652_b36-ol-0-0-10012","doi-asserted-by":"publisher","first-page":"4647","DOI":"10.1158\/1078-0432.CCR-13-2391","article-title":"Nondisruptive p53 mutations are associated with shorter survival in patients with advanced non-small cell lung cancer","volume":"20","author":"Molina-Vila","year":"2014","journal-title":"Clin Cancer Res"},{"key":"key20200714085652_b37-ol-0-0-10012","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.lungcan.2013.03.019","article-title":"Prognostic value of K-RAS mutations in patients with non-small cell lung cancer: A systematic review with meta-analysis","volume":"81","author":"Meng","year":"2013","journal-title":"Lung Cancer"},{"key":"key20200714085652_b38-ol-0-0-10012","doi-asserted-by":"crossref","first-page":"7521","DOI":"10.1200\/jco.2015.33.15_suppl.7521","article-title":"Prognostic effect of single versus multiple somatic mutations in non-small cell lung cancer (NSCLC)","volume":"33","author":"Jao","year":"2015","journal-title":"J Clin Oncol"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T09:47:48Z","timestamp":1594720068000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2019.10012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,4]]},"references-count":38,"URL":"https:\/\/doi.org\/10.3892\/ol.2019.10012","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,4]]}}}